1. Home
  2. ZBH vs TROW Comparison

ZBH vs TROW Comparison

Compare ZBH & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBH
  • TROW
  • Stock Information
  • Founded
  • ZBH 1927
  • TROW 1937
  • Country
  • ZBH United States
  • TROW United States
  • Employees
  • ZBH N/A
  • TROW N/A
  • Industry
  • ZBH Industrial Specialties
  • TROW Investment Bankers/Brokers/Service
  • Sector
  • ZBH Health Care
  • TROW Finance
  • Exchange
  • ZBH Nasdaq
  • TROW Nasdaq
  • Market Cap
  • ZBH 21.8B
  • TROW 25.7B
  • IPO Year
  • ZBH N/A
  • TROW N/A
  • Fundamental
  • Price
  • ZBH $104.83
  • TROW $106.27
  • Analyst Decision
  • ZBH Hold
  • TROW Sell
  • Analyst Count
  • ZBH 23
  • TROW 11
  • Target Price
  • ZBH $124.43
  • TROW $115.09
  • AVG Volume (30 Days)
  • ZBH 2.0M
  • TROW 1.7M
  • Earning Date
  • ZBH 02-06-2025
  • TROW 02-05-2025
  • Dividend Yield
  • ZBH 0.92%
  • TROW 4.78%
  • EPS Growth
  • ZBH N/A
  • TROW 17.91
  • EPS
  • ZBH 4.43
  • TROW 9.15
  • Revenue
  • ZBH $7,678,600,000.00
  • TROW $7,093,600,000.00
  • Revenue This Year
  • ZBH $3.68
  • TROW $7.96
  • Revenue Next Year
  • ZBH $4.53
  • TROW $4.01
  • P/E Ratio
  • ZBH $23.66
  • TROW $11.61
  • Revenue Growth
  • ZBH 3.85
  • TROW 9.80
  • 52 Week Low
  • ZBH $97.69
  • TROW $100.49
  • 52 Week High
  • ZBH $133.90
  • TROW $125.81
  • Technical
  • Relative Strength Index (RSI)
  • ZBH 48.37
  • TROW 33.27
  • Support Level
  • ZBH $99.43
  • TROW $106.63
  • Resistance Level
  • ZBH $108.88
  • TROW $108.16
  • Average True Range (ATR)
  • ZBH 2.23
  • TROW 2.00
  • MACD
  • ZBH 0.02
  • TROW -0.33
  • Stochastic Oscillator
  • ZBH 58.67
  • TROW 5.24

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

About TROW T. Rowe Price Group Inc.

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of August 2024, the firm had $1.612 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.

Share on Social Networks: